Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases.
Gauckler P, Kesenheimer JS, Geetha D, Odler B, Eller K, Laboux T, Alberici F, Zappa M, Chebotareva N, Moiseev S, Bonilla M, Jhaveri KD, Oniszczuk J, Audard V, Costa D, Mastroianni-Kirsztajn G, Bruchfeld A, Muto M, Windpessl M, Mayer G, Kronbichler A. Gauckler P, et al. Among authors: audard v. Front Immunol. 2023 Sep 12;14:1228457. doi: 10.3389/fimmu.2023.1228457. eCollection 2023. Front Immunol. 2023. PMID: 37767096 Free PMC article.
CMIP is a negative regulator of T cell signaling.
Oniszczuk J, Sendeyo K, Chhuon C, Savas B, Cogné E, Vachin P, Henique C, Guerrera IC, Astarita G, Frontera V, Pawlak A, Audard V, Sahali D, Ollero M. Oniszczuk J, et al. Among authors: audard v. Cell Mol Immunol. 2020 Oct;17(10):1026-1041. doi: 10.1038/s41423-019-0266-5. Epub 2019 Aug 8. Cell Mol Immunol. 2020. PMID: 31395948 Free PMC article.
De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant.
Oniszczuk J, Moktefi A, Mausoleo A, Pallet N, Malard-Castagnet S, Fourati S, El Karoui K, Sahali D, Stehlé T, Boueilh A, Verpont MC, Matignon M, Buob D, Grimbert P, Audard V. Oniszczuk J, et al. Among authors: audard v. Transplantation. 2021 Jan 1;105(1):206-211. doi: 10.1097/TP.0000000000003432. Transplantation. 2021. PMID: 32852403
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Gauckler P, et al. Among authors: audard v. Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15. Autoimmun Rev. 2020. PMID: 32942039 Free article. Review.
Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults.
Oniszczuk J, Beldi-Ferchiou A, Audureau E, Azzaoui I, Molinier-Frenkel V, Frontera V, Karras A, Moktefi A, Pillebout E, Zaidan M, El Karoui K, Delfau-Larue MH, Hénique C, Ollero M, Sahali D, Mahévas M, Audard V. Oniszczuk J, et al. Among authors: audard v. Nephrol Dial Transplant. 2021 Mar 29;36(4):609-617. doi: 10.1093/ndt/gfaa279. Nephrol Dial Transplant. 2021. PMID: 33241414
226 results